• 2019-05-16

    1.论批生产记录设计的有效性对产品质量追溯的影响——以公司内胶囊及片剂产品批生产记录为例 2.Federal Health bulletin 4(1961)12:189 需要这个文献 3.Morton RF, et al. Studies on the absorption, diffusion, and excretion of cycloserine. Antibiot Annu 1955-56; 3: 169-72. 4.Acta Gastroenterol Belg.1969,32(10):771-777 A NEW ANTISPASMODIC DRUG IN THE TREATMENT OF BILIARY AND INTESTINAL DISCASCS:A CLINICAL TEST. 5.a process for preparing (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one https://priorart.ip.com/IPCOM/000238343

    信息服务
    剩余时间:
  • 2019-04-29

    1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1, Cini C1, Butterfield DA2, Barone E1,3. 9.A multicenter study comparing the efficacy and tolerability of nisoldipine coat-core and amlodipine in patients with chronic stable angina Current Therapeutic Research Volume 59, Issue 7, July 1998, Pages 483-497 10.Procedure for the preparation of tetrahydro-1H-β-carboline-3-carboxylic acid esters 11.Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes 12.Characterization of different crystal forms of iboprofen, tinidazole and lorazepan Udupa, N. Drug Development and Industrial 13.Effect of Crystallinity on Absorption and Excretion Patterns of Ibuprofen, Tinidazole and Lorazepam 14.Sa1095 - (In)Appropriate Use of Proton Pump Inhibitors in Gastroesophageal Reflux Disease 15.Mo1512 - Treatment of Functional Chest Pain: Citalopram, Amitriptylin or no Treatment 16.Sa1089 - A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan (20 Mg Once Daily) Compared to Lansoprazole (30 Mg Once-Daily) in Patients with Erosive Esophagitis (Ee) 17.Mo1195 - Effect of a New Pptent Acid Inhibitor Drug, Vonoprazan on Healing Rate of Idiopathic Peptic Ulcers 18.Mo1194 - Natural History of Gastric Ulcer in a 25 Years Follow-Up: Role of Helicobacter Pylori Infection and Nonsteroidal Anti-Inflammatory Drugs 19.Anorexia, vomiting and weight loss in a 22-year-old woman 20.https://econtent.hogrefe.com/doi/abs/10.1024/0300-9831/a000523?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=vit 21.文献:Drugs Fut 2001, 26(2): 141 ISSN 0377-8282 Copyright 2001 Clarivate Analytics CCC: 0377-8282 DOI: 10.1358/dof.2001.026.02.610068 Vardenafil Sorbera, L.A., Martin, L., Rabasseda, X., Castaner, J. 22.Review:Solubilizing excipients in oral and injectable formulations. Pharmaceutical Research 21(2).february Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation 23.JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 196,478,1976 24.Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation

    信息服务
    已完成
  • 2019-04-28

    1.丙氨酰谷氨酰胺及其注射液的研究开发 2.A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study). Cimminiello C, Arpaia G, Polo Friz H, Boracchi P, Marano G, Spezzigu G, Visonà A. Vasa. 2015 Sep;44(5):371-9. doi: 10.1024/0301-1526/a000456. 3.2013 International Conference on Materials Engineering, ICMEN 2013 4.Orientation of substitution in the aromatic series. XVIII. Sulfonation of phenol by chlorosulfonic acid in solvents 5.Mechanism of reaction of chlorosulfonic acid with some aromatic compounds 6.Arzneimittelforschung. 1982;32(3):248-51. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing. 7.Oral treatment with the Crataegus special extract WS 1442 inhibits cardiac hypertrophy in rats with DOCA-salt or aortic banding induced hypertension

    信息服务
    已结束
  • 2019-04-28

    1.Nakashima M, Morita J, Aizawa K. Pharamacokinetics and safety of tebipenem pivoxil fine granules, an oral carbapenem antibiotic, in healthy male volunteers. Jpn J Chemother. 2009;57(S–1):90–94 2.Baba S, Yamanaka N, Suzuki K, et al. Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections. Jpn J Antibiot. 2009;62:155–177 3.Sunakawa K. Pharmacological properties and clinical performance of the novel oral carbapenem antimicrobial drug, “Tebipenem pivoxil” (Orapenem fine granules 10% for pediatric use). Jpn J Chemother. 2009;57:279–294 4.Yamanaka N, Furukawa M, Furuya, et al. Clinical efficacy of tebipenem pivoxil (ME1211), a novel oral carbapenem, in otolaryngological infections, a Phase II clinical trial (1). 45th Intersci Conf Antimicrob Agents Chemother (ICAAC) 2005; Abstract L-577 5.Iwata S, Ouchi K, Iwata N, et al. An open clinical study of tebipenem pivoxil in children with bacterial pneumonia. Jpn J Chemother. 2009;57(S–1):137–150

    信息服务
    已结束
  • 2019-04-16

    1、Atropine and scopolamine premedication – Pharmacological aspects and present use in Finland 2、Identification and purity test of heparin by NMR - a summary of two years' experience at the Medical Products Agency By: McEwen I; Amini A; Olofsson I M 3、Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti 4、49-12 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 1. Absorption, Distribution and Excretion in Rats after Single … S Takeda, E Ono, Y Matsuzaki… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri … 5、49-13 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 2. Metabolism study in Rats Using 14C-TJA 250 S Takeda, E Ono, Y Wakui… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri …

    信息服务
    已结束
  • 5
  • 交易量
  • 480
  • 赏金

最近10位访客
  • 药智客

    05-16 18:48
  • 药智客

    05-16 10:40
  • 药智客

    05-16 00:57
  • 药智客

    05-14 23:49
  • 药智客

    05-14 15:04
  • 药智客

    04-23 15:17
  • 药智客

    04-22 16:42
  • 药智客

    04-17 13:05
  • 药智客

    04-17 12:05